EnzymeRx

EnzymeRx! A private clinical-stage biotechnology company developing uricase-PEG 20 for the treatment of drug-resistant and refractory gout and related indications, where hyperuricemia plays a pathogenic role. Our patented formulation of pegylated uricase has a longer half-life and lower immunogenicity.